Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on Aug 9, 2015 in Colorectal cancer | 0 comments

In a nutshell

This study examined whether levels of microRNA-21 could predict the patient response to chemo-radiotherapy delivered before they had surgery.

Some background

Almost a third of colorectal cancer is rectal cancer. The treatment for this cancer which has started to spread is a combination of chemotherapy, radiotherapy (known as chemo-radiotherapy) and surgery. 

Radiotherapy uses high-energy radiation to kill cancer cells by damaging their DNA while chemotherapy uses a combination of drugs to kill the cancer cells.
This chemo-radiotherapy has been shown in other studies to work better when given before surgery.
However, more than 50% of patients do not respond to this treatment. This can delay their surgery.

Methods & findings

The current study examined whether microRNA-21 levels could predict patient response to chemo-radiotherapy delivered prior to surgery.

The records of 92 rectal adenocarcinoma patients who underwent chemo-radiotherapy before surgery were examined in this study. In each patient the cancer had started to spread from its original site but had not reached other organs. Each patient received 5-fluoracil (Efudex) or capecitabine (Xeloda) chemotherapy and underwent surgery 6-8 weeks following treatment.

MicroRNA-21 levels were raised in almost 78% of rectal cancer patients.

Lower levels of microRNA-21 were associated with a better response to treatment. Of the 56 patients who had high levels of microRNA-21, 7.2% showed a complete response to chemo-radiotherapy and 92.8% had a non-complete response. Of the 14 patients with lower levels of microRNA-21, 42.8% showed a complete response.

Patients with high levels of microRNA-21 were 9.75 times more likely to show a poor response to chemo-radiotherapy compared to those with lower levels.

The bottom line

The authors concluded that the levels of preoperative microRNA-21 could be used for predicting response to chemo-radiotherapy treatment.

The fine print

The study would benefit from being repeated over a longer period of time and with more patients.

What’s next?

Discuss this article and microRNA-21 levels with your doctor.

Published By :

International Journal of Colorectal Disease

Date :

May 08, 2015

Original Title :

MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

click here to get personalized updates